RESEARCH & DEVELOPMENT

 

RESEARCH & DEVELOPMENT

 

PHARMACEUTICAL

At AntalGenics we develop novel therapeutic leads, mainly for the treatment of psoriatic pruritus and psoriatic comorbidities, such as arthritis

COSMECEUTICAL

AntalGenics has extensive experience in the development of cosmetics. We develop innovative compounds to manage sensitive skin conditions by targeting neurogenic inflammation

OUR R&D STRATEGY

PHARMACEUTICAL

Our R&D programme is focused on the discovery and development of new molecules to treat chronic painful disorders. Our scientific team has a long-track experience in pain research. With this knowledge, we are currently developing two new molecular entities to provide precise innovative therapies for psoriatic pruritus and osteoarthritic pain

COSMECEUTICAL

Our team has a proven track record of bringing new cosmeceutical products to market with the main goal to improve skin care by science.

Our cosmeceutical programme is currently focusing its target compounds on mild atopia, dermatitis (contact, seborrheic, allegenic, stress, etc.) and rosacea.

ANTALGENICS OFFERS

Proven-track record in pain research
Specialists in ion channel research and neuronal exocytosis
Full access to University infrastructures
Skilled team in sensory biology
Rich-network of partner research groups
Experts in molecular modeling and in silico screening
A long standing experience in cosmeceutics